Clinical Trials
5 trialsNCT03969823 2026-04-24
Whole Genomic Landscape of Advanced EGFR-mutant NSCLC
Seoul National University Hospital
Phase NA Active not recruiting
NCT06304441 2025-09-29
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs (e.g. 'Osimertinib') Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Guangzhou Medical University
Phase NA Recruiting
NCT06709274 2024-11-29
MOTION-NSCLC
Guangdong Association of Clinical Trials
Phase NA Not yet recruiting
NCT05583409 2022-10-17
SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC
Tongji Hospital
Phase NA Unknown
NCT04816838 2021-08-25
A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Neoadjuvant Osimertinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harbouring EGFR Mutations
Yonsei University
Phase NA Unknown